U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130097) titled 'A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants' on Aug. 12.
Brief Summary: The purpose of this study is to understand bioequivalence (medicines that may have different names or be made in different ways, but have the same effect on the body) of the current PF-07220060 tablet formulation and the proposed higher drug load tablet that is already available in the market.
The study is seeking participants who are:
* Healthy males and females aged 18 to 65 years
* Willing and able to comply with all scheduled visits, treatment plan, lifestyle considerations, and other study procedures....